Log in
Enquire now

List of Aileron Therapeutics patents

List of Aileron Therapeutics patents
List of Zillow Group patents
List of BJ Services Company patents
List of Powerwave Technologies patents
List of funding rounds for SiBeam
List of nuclear-powered aircraft carrier patents
Patents where
Current Assignee
Name
is
Aileron TherapeuticsAileron Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8927500 Peptidomimetic macrocycles

Patent 8927500 was granted and assigned to Aileron Therapeutics on January, 2015 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8927500
January 6, 2015
‌
US Patent 9505804 Peptidomimetic macrocycles

Patent 9505804 was granted and assigned to Aileron Therapeutics on November, 2016 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9505804
November 29, 2016
‌
US Patent 8637686 Triazole macrocycle systems

Patent 8637686 was granted and assigned to Aileron Therapeutics on January, 2014 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8637686
January 28, 2014
‌
US Patent 8071541 Methods for preparing internally constrained peptides and peptidomimetics

Patent 8071541 was granted and assigned to Aileron Therapeutics on December, 2011 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8071541
December 6, 2011
‌
US Patent 9175045 Peptidomimetic macrocycles

Patent 9175045 was granted and assigned to Aileron Therapeutics on November, 2015 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9175045
November 3, 2015
‌
US Patent 7981999 Triazole macrocycle systems

Patent 7981999 was granted and assigned to Aileron Therapeutics on July, 2011 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7981999
July 19, 2011
‌
US Patent 9522947 Peptidomimetic macrocycles

Patent 9522947 was granted and assigned to Aileron Therapeutics on December, 2016 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9522947
December 20, 2016
‌
US Patent 10300109 Peptidomimetic macrocycles

Patent 10300109 was granted and assigned to Aileron Therapeutics on May, 2019 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10300109
May 28, 2019
‌
US Patent 9096684 Peptidomimetic macrocycles

Patent 9096684 was granted and assigned to Aileron Therapeutics on August, 2015 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9096684
August 4, 2015
‌
US Patent 10905739 Peptidomimetic macrocycles and formulations thereof

Patent 10905739 was granted and assigned to Aileron Therapeutics on February, 2021 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10905739
February 2, 2021
‌
US Patent 7981998 Bis-sulfhydryl macrocyclization systems

Patent 7981998 was granted and assigned to Aileron Therapeutics on July, 2011 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7981998
July 19, 2011
‌
US Patent 7960506 Bis-sulfhydryl macrocyclization systems

Patent 7960506 was granted and assigned to Aileron Therapeutics on June, 2011 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7960506
June 14, 2011
‌
US Patent 8399405 Peptidomimetic macrocycles

Patent 8399405 was granted and assigned to Aileron Therapeutics on March, 2013 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8399405
March 19, 2013
‌
US Patent 10059741 Peptidomimetic macrocycles

Patent 10059741 was granted and assigned to Aileron Therapeutics on August, 2018 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10059741
August 28, 2018
‌
US Patent 10030049 Triazole macrocycle systems

Patent 10030049 was granted and assigned to Aileron Therapeutics on July, 2018 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10030049
July 24, 2018
‌
US Patent 10023613 Peptidomimetic macrocycles as modulators of MCL-1

Patent 10023613 was granted and assigned to Aileron Therapeutics on July, 2018 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10023613
July 17, 2018
‌
US Patent 10246491 Peptidomimetic macrocycles and use thereof in regulating HIF1alpha

Patent 10246491 was granted and assigned to Aileron Therapeutics on April, 2019 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10246491
April 2, 2019
‌
US Patent 10308699 Peptidomimetic macrocycles

Patent 10308699 was granted and assigned to Aileron Therapeutics on June, 2019 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10308699
June 4, 2019
‌
US Patent 9175047 Peptidomimetic macrocycles

Patent 9175047 was granted and assigned to Aileron Therapeutics on November, 2015 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9175047
November 3, 2015
‌
US Patent 8808694 Therapeutic peptidomimetic macrocycles

Patent 8808694 was granted and assigned to Aileron Therapeutics on August, 2014 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8808694
August 19, 2014
‌
US Patent 10213477 Peptidomimetic macrocycles

Patent 10213477 was granted and assigned to Aileron Therapeutics on February, 2019 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10213477
February 26, 2019
‌
US Patent 10967042 Peptidomimetic macrocycles

Patent 10967042 was granted and assigned to Aileron Therapeutics on April, 2021 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10967042
April 6, 2021
‌
US Patent 10669230 Disubstituted amino acids and methods of preparation and use thereof

Patent 10669230 was granted and assigned to Aileron Therapeutics on June, 2020 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10669230
June 2, 2020
‌
US Patent 10253067 Peptidomimetic macrocycles and uses thereof

Patent 10253067 was granted and assigned to Aileron Therapeutics on April, 2019 by the United States Patent and Trademark Office.

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10253067
April 9, 2019
‌
US Patent 10703780 Peptidomimetic macrocycles

Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
Aileron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10703780
July 7, 2020
Results per page:
44 results
0 selected
44 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us